Related Experiment Video

Updated: May 21, 2026

Assessment of the Metabolic Profile of Primary Leukemia Cells
06:21

Assessment of the Metabolic Profile of Primary Leukemia Cells

Published on: November 21, 2018

[Plasma fatty acids profile in paediatric cancer patients]

M J de la Torre Aguilar1, A Cox Belmonte, M D Mesa-García

  • 1Pediatra EBAP, Unidad de Metabolismo e Investigación Pediátrica, Hospital Universitario Reina Sofía, Córdoba, España.

Nutricion Hospitalaria
|June 27, 2012
PubMed

Insights

Pediatric cancer patients receiving chemotherapy showed altered omega-3 and omega-6 fatty acid metabolism, despite normal nutritional status. Further research is needed to guide targeted supplementation for these children.

Area of Science:

  • Biochemistry
  • Pediatric Oncology
  • Nutritional Science

Context:

  • Limited research exists on the metabolic and nutritional status of pediatric cancer patients.
  • Chemotherapy can significantly impact a child's overall health and metabolic processes.

Purpose:

  • To investigate nutritional and metabolic alterations in children with cancer.
  • To specifically analyze plasma fatty acid profiles post-chemotherapy compared to healthy controls.

Summary:

  • Twelve children (0-16 years) with cancer, who had received chemotherapy, were assessed for nutritional status, anthropometry, and plasma fatty acids.
  • Results indicated no changes in anthropometric or general biochemical parameters, but revealed alterations in omega-3 and omega-6 polyunsaturated fatty acids.

Impact:

  • Suggests a potential partial deficiency in polyunsaturated fatty acid metabolism in pediatric cancer patients post-chemotherapy.
  • Highlights the need for further research to develop specific nutritional supplementation strategies for improved patient outcomes.
Abstract

More Related Videos

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...